National Health Amendment (Passive Immunological Products) Bill 2026
Amends the National Health Act 1953 to amend the definition of ‘vaccine’ to enable new and merging technologies to be listed on the National Immunisation Program.
Summary from the official bill homepage.
Divisions on this bill
- 1 Apr 2026National Health Amendment (Passive Immunological Products) Bill 2026 - Limitation of Debate - Vaccines to be tested against an inert saline placeboSenate 5–43
- 1 Apr 2026National Health Amendment (Passive Immunological Products) Bill 2026 - Limitation of Debate - Pass the billSenate 39–5
Official record: bill homepage at aph.gov.au.